All the data of this study were collected after agreement with the patient,
Conditions
Interventions
Since oxytocin is a peptide,
delivery through intranasal path is considered as a preferred method in clinical studies (7). Oxytocin intranasal spray (Syntocinon(®)
Experimental Drug
Sponsors
none
Eligibility
Sex/Gender
Male
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: single-case design structure
Exclusion criteria
Exclusion criteria: single-case design structure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Addiction severity 14 months and 44 evaluations Addiction severity index | — |
Secondary
| Measure | Time frame |
|---|---|
| emotion regulation 14 months and 44 evaluations Difficulties in Emotion Regulation Scale (DERS) | — |
Countries
iran
Contacts
Public Contactbijan pirnia
Bijan Center
Outcome results
None listed